Advertisement
Screener

Starling Oncology, Inc. (DFPH) APIC, Share-based Payment Arrangement, Increase for Cost Recognition

3.3 / 5 stars · 23/35 Roast Me

Starling Oncology, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition

Starling Oncology, Inc. (DFPH) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Shareholders' Equity

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06

  • Starling Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $1.07M, a 42.29% increase year-over-year.
  • Starling Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $1.69M, a 15.64% increase year-over-year.
  • Starling Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $1.02M, a 57.14% decline year-over-year.
  • Starling Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $752.00K, a 77.80% decline year-over-year.
  • Starling Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $4.55M, a 59.19% decline from fiscal 2024.
  • Starling Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $11.15M, a 37.38% decline from fiscal 2023.
  • Starling Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $17.81M, a 35.05% decline from fiscal 2022.
  • Starling Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $27.42M, a 11.75% increase from fiscal 2021.
Period endAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month
2026-06-30$1.07M
10-Q · filed 2026-08-06
$2.76M
derived: sum of 2 quarters · filed 2026-08-06
2026-03-31$1.69M
10-Q · filed 2026-08-06
2025-12-31$4.55M
10-K · filed 2026-03-12
2025-09-30$1.02M
10-Q · filed 2025-11-13
$1.78M
derived: sum of 2 quarters · filed 2026-08-06
$3.23M
derived: sum of 3 quarters · filed 2026-08-06
2025-06-30$752.00K
10-Q · filed 2026-08-06
$2.21M
derived: sum of 2 quarters · filed 2026-08-06
2025-03-31$1.46M
10-Q · filed 2026-08-06
2024-12-31$11.15M
10-K · filed 2026-03-12
2024-09-30$2.39M
10-Q · filed 2025-11-13
$5.78M
derived: sum of 2 quarters · filed 2025-11-13
$9.86M
derived: sum of 3 quarters · filed 2025-11-13
2024-06-30$3.39M
10-Q · filed 2025-11-13
$7.47M
derived: sum of 2 quarters · filed 2025-11-13
2024-03-31$4.09M
10-Q · filed 2025-11-13
2023-12-31$17.81M
10-K · filed 2025-03-26
2023-09-30$4.66M
10-Q · filed 2024-11-13
$8.76M
derived: sum of 2 quarters · filed 2024-11-13
$13.99M
derived: sum of 3 quarters · filed 2024-11-13
2023-06-30$4.11M
10-Q · filed 2024-11-13
$9.34M
derived: sum of 2 quarters · filed 2024-11-13
2023-03-31$5.23M
10-Q · filed 2024-11-13
2022-12-31$27.42M
10-K · filed 2024-03-28
2022-09-30$6.55M
10-Q · filed 2023-11-08
$13.06M
derived: sum of 2 quarters · filed 2023-11-08
$21.61M
derived: sum of 3 quarters · filed 2023-11-08
2022-06-30$6.51M
10-Q · filed 2023-11-08
$15.07M
derived: sum of 2 quarters · filed 2023-11-08
2022-03-31$8.55M
10-Q · filed 2023-11-08
2021-12-31$24.54M
10-K · filed 2023-03-16
2021-09-30$60.00K
10-Q · filed 2022-11-09
$111.00K
derived: sum of 2 quarters · filed 2022-11-09
$153.00K
derived: sum of 3 quarters · filed 2022-11-09
2021-06-30$51.00K
10-Q · filed 2022-11-09
$93.00K
derived: sum of 2 quarters · filed 2022-11-09
2021-03-31$42.00K
10-Q · filed 2022-11-09
2020-12-31$151.00K
10-K · filed 2022-03-11